Skip to main content
Premium Trial:

Request an Annual Quote

Keith Elliston, Douglas Danne, John McAlister


After some time off following the split of Viaken Systems into two entities in June, Keith Elliston, founder and former CEO of Viaken, has resurfaced as CEO of Genstruct of Cambridge, Mass. Prior to founding Viaken in 1999, Elliston was the senior vice president of R&D and chief scientific officer at Gene Logic. He also founded the bioinformatics and genomics efforts of Bayer AG, where he was the worldwide head of bioinformatics and the section head for genomics, and spent 10 years in Merck’s computational molecular biology group. Elliston also holds a seat on Genstruct's board of directors.

Douglas Danne, formerly senior vice president and chief commercial officer of St. Louis-based Tripos, has left the company. CEO John McAlister said in a statement that the company is initiating a search for a replacement. Further details regarding Danne's departure were not provided.

Filed under

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.